Skip to main content

Table 1 Prevalence of MDR and key resistances in E. coli isolates

From: A one-year genomic investigation of Escherichia coli epidemiology and nosocomial spread at a large US healthcare network

 

Total (n)

MDR (%)

Non-MDR (%)

ESBLb (%)

FLQc (%)

All

2075

29

71

6

17

 Cluster

258

36

64

6

23

 Non-cluster

1817

28

72

6

16

Deduplicateda

1828

27

73

5

15

 Cluster

228

35

65

6

21

 Non-cluster

1600

26

74

5

14

B2

1290

26

74

4

16

 Cluster

186

33

67

5

22

 Non-cluster

1104

25

75

4

15

 ST-131

215

64

36

16

52

  Cluster

36

72

28

22

56

  Non-cluster

179

63

37

13

49

 ST-73

204

21

79

1

0

  Cluster

41

29

71

5

0

  Non-cluster

163

20

80

1

1

 ST-95

196

7

93

0

0

  Cluster

21

24

76

0

0

  Non-cluster

175

5

95

0

0

 ST-127

125

13

87

0

0

  Cluster

21

24

76

0

0

  Non-cluster

104

11

89

0

0

 ST-1193

89

55

45

7

100

  Cluster

17

53

47

0

100

  Non-cluster

72

56

44

9

100

D

243

40

60

8

11

 Cluster

42

48

52

7

12

 Non-cluster

201

39

61

8

10

 ST-69

128

43

57

4

6

  Cluster

21

47

53

0

4

  Non-cluster

107

42

58

5

6

  1. aDeduplicated = primary isolate of each ST per patient
  2. bPresence of extended-spectrum β-lactamases
  3. cPhenotypic non-susceptibility to ciprofloxacin and levofloxacin